William J. Litchy

TL;DR: Inotersen improved the course of neurologic disease and quality of life in patients with hereditary transthyretin amyloidosis and improvements were independent of disease stage, mutation type, or the presence of cardiomyopathy.

TL;DR: Both treatments are efficacious in ameliorating neurological deficit in chronic inflammatory demyelinating polyradiculoneuropathy and the frequency and dosage needed to maintain good function could be titrated by assessing the neurological disability score and the summated muscle action potentials at 6‐week intervals.

TL;DR: Two kindreds with an autosomal dominant inherited disorder characterized by a variable degree of muscle weakness of limbs, vocal cords, and intercostal muscles and by asymptomatic sensory loss, beginning in infancy or childhood in severely affected persons are described.

TL;DR: The early hyperalgesia on the CAPS side is interpreted as being responsible for the better performance of PLAC at early time points, and the large percentage of limbs that improved may be a pronounced PLAC response.

TL;DR: Routine pulmonary function tests may be useful for screening for reductions in nocturnal oxygen saturation and also may have prognostic value, according to the results of spirometry, which was compared with several formal polysomnographic variables.